Maculaser’s Chief Scientific Officer Teemu Turunen presented the results of our clinical usability trial in Visionarium XX, an acknowledged conference for wide-scope vision research. The trial was an important milestone on our way to clinical trials investigating the safety/efficacy of the laser-induced heat shock therapy of the retina.
